Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel, Oxaliplatin, and 5-FU in Advanced Solid Tumors
NCT00711243Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Apr 2005
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in solid tumor, gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Northwestern University. Started Apr 2005; status: completed.
02
Drugs
docetaxel
03
Conditions
solid tumorgastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00711243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00711243.